You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 3, March 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Critical Care/ Intensive Care Medicine
 •Oncology
 •Head & Neck Cancer
 •Critical Care Medicine, Other
 •Neoplasms of Head & Neck
 •Alert me on articles by topic

Clinical Care Pathway for Head and Neck Cancer

A Valuable Tool for Decreasing Resource Utilization

Kristin M. Gendron, MD; Stephen Y. Lai, MD, PhD; Gregory S. Weinstein, MD; Ara A. Chalian, MD; Julian M. Husbands, MD; Patricia F. Wolf, BS; Liesje DiDonato, BS; Randal S. Weber, MD

Arch Otolaryngol Head Neck Surg. 2002;128:258-262.

Objective  To evaluate the durability over time of the reduction of resource utilization after implementing a clinical care pathway (CCP) for head and neck cancer surgery.

Design  Cohort study.

Setting  A tertiary care academic medical center.

Patients  We studied control subjects from 1995 (pre-CCP) (n = 87), a cohort from July 1, 1996, through July 31, 1997 (the first year after CCP implementation) (n = 43), and a cohort from 1999 (n = 82) after major resection and tracheostomy for upper aerodigestive tract cancer.

Interventions  Starting July 1, 1996, all patients undergoing major resection for head and neck cancer were treated using a CCP, which delineates daily interventions and goals.

Main Outcome Measures  Length of stay (LOS), readmission and complication rates, and hospital charges.

Results  Median total LOS and LOS exclusive of the intensive care unit decreased in the first year and remained stable at 3 years (from 13.0 to 8.0 days and from 10.5 to 6.4 days, respectively). The intensive care unit LOS decreased across 3 years from 2.2 to 1.1 days (P= .001). Median total charges declined from $105 410 pre-CCP to $65 919 at 3 years. Incidence of postoperative pneumonia decreased from 12% to 1% (P= .02), and readmission rate decreased from 18% to 11% (P= .37) across 3 years.

Conclusions  The CCP for head and neck cancer maintained the improvement in LOS and charges seen in the first year of implementation and continues to decrease resource utilization while enhancing quality of care.


From the Departments of Otorhinolaryngology–Head and Neck Surgery (Drs Gendron, Lai, Weinstein, Chalian, and Weber and Mss Wolf and DiDonato) and Surgery (Dr Husbands), University of Pennsylvania Health System, Philadelphia.


RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2002;128(3):332-334.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improving the Quality of Head and Neck Cancer Care
Weber
Arch Otolaryngol Head Neck Surg 2007;133:1188-1192.
ABSTRACT | FULL TEXT  

A Critical Evaluation of Critical Pathways in Head and Neck Cancer
Yueh et al.
Arch Otolaryngol Head Neck Surg 2003;129:89-95.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.